Accès gratuit
Numéro
Réanimation
Volume 24, Numéro 2, Mars 2015
Cardiovasculaire
Page(s) 98 - 103
Section Mise Au Point / Update
DOI https://doi.org/10.1007/s13546-015-1039-5
Publié en ligne 27 février 2015
  • Goldhaber SZ, Visani L, De Rosa M. (1999) Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 353:1386–1389 [CrossRef] [PubMed] [Google Scholar]
  • Kasper W, Konstantinides S, Geibel A, et al (1997) Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol 30:1165–1171 [CrossRef] [PubMed] [Google Scholar]
  • Buller HR, Prins MH, Lensin AW, et al (2012) Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med 366:1287–1297 [CrossRef] [PubMed] [Google Scholar]
  • Konstantinides SV, Torbicki A, Agnelli G, et al (2014) 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 35:3033–3069 [CrossRef] [PubMed] [Google Scholar]
  • Jimenez D, Kopecna D, Tapson V, et al (2014) Derivation and validation of multimarker prognostication for normotensive patients with acute symptomatic pulmonary embolism. Am J Respir Crit Care Med 189:718–726 [CrossRef] [PubMed] [Google Scholar]
  • Sanchez O, Trinquart L, Caille V, et al (2010) Prognostic factors for pulmonary embolism: the prep study, a prospective multicenter cohort study. Am J Respir Crit Care Med 181:168–173 [CrossRef] [PubMed] [Google Scholar]
  • Lankeit M, Jimenez D, Kostrubiec M, et al (2014) Validation of N-terminal pro-brain natriuretic peptide cut-off values for risk stratification of pulmonary embolism. Eur Respir J 43:1669–1677 [CrossRef] [PubMed] [Google Scholar]
  • Aujesky D, Obrosky DS, Stone RA, et al (2005) Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 172:1041–1046 [CrossRef] [PubMed] [Google Scholar]
  • Jimenez D, Aujesky D, Moores L, et al (2010) Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med 170:1383–1389 [CrossRef] [PubMed] [Google Scholar]
  • Dalla-Volta S, Palla A, Santolicandro A, et al (1992) PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2. J Am Coll Cardiol 20:520–526 [CrossRef] [PubMed] [Google Scholar]
  • Goldhaber SZ, Haire WD, Feldstein ML, et al (1993) Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet 341:507–511 [CrossRef] [PubMed] [Google Scholar]
  • 1973) The urokinase pulmonary embolism trial. A national cooperative study. Circulation 47:II1–II108. [CrossRef] [PubMed] [Google Scholar]
  • 1990) Tissue plasminogen activator for the treatment of acute pulmonary embolism. A collaborative study by the PIOPED Investigators. Chest 97:528–533. [CrossRef] [PubMed] [Google Scholar]
  • Dotter CTSA, Rösch J, Poter JM. (1979) Streptokinase and heparin in the treatment of pulmonary embolism: a randomized comparison. Vascular Surgery 13:42–52 [CrossRef] [Google Scholar]
  • Levine M, Hirsh J, Weitz J, et al (1990) A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism. Chest 98:1473–1479 [CrossRef] [PubMed] [Google Scholar]
  • Jerjes-Sanchez C, Ramirez-Rivera A, de Lourdes Garcia M, et al (1995) Streptokinase and Heparin versus Heparin Alone in Massive Pulmonary Embolism: A Randomized Controlled Trial. J Thromb Thrombolysis 2:227–229 [CrossRef] [PubMed] [Google Scholar]
  • Konstantinides S, Geibel A, Heusel G, et al (2002) Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 347:1143–1150 [CrossRef] [PubMed] [Google Scholar]
  • Ly B, Arnesen H, Eie H, Hol R. (1978) A controlled clinical trial of streptokinase and heparin in the treatment of major pulmonary embolism. Acta Med Scand 203:465–470 [CrossRef] [PubMed] [Google Scholar]
  • Marini C, Di Ricco G, Rossi G, et al (1988) Fibrinolytic effects of urokinase and heparin in acute pulmonary embolism: a randomized clinical trial. Respiration 54:162–173 [CrossRef] [PubMed] [Google Scholar]
  • Tibbutt DA, Davies JA, Anderson JA, et al (1974) Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonay embolism. Br Med J 1:343–347 [CrossRef] [PubMed] [Google Scholar]
  • Wan S, Quinlan DJ, Agnelli G, Eikelboom JW. (2004) Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials. Circulation 110:744–749 [CrossRef] [PubMed] [Google Scholar]
  • Konstantinides S, Geibel A, Olschewski M, et al (1997) Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry. Circulation 96:882–888 [CrossRef] [PubMed] [Google Scholar]
  • Riera-Mestre A, Jimenez D, Muriel A, et al (2012) Thrombolytic therapy and outcome of patients with an acute symptomatic pulmonary embolism. J Thromb Haemost 10:751–759 [CrossRef] [PubMed] [Google Scholar]
  • Meyer GVE, Danays T, Agnelli G, et al (2014) Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med 370:1402–1411 [CrossRef] [PubMed] [Google Scholar]
  • Kline JA, Nordenholz KE, Courtney DM, et al (2014) Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double-blind, placebo-controlled randomized trial. J Thromb Haemost 12:459–468 [CrossRef] [PubMed] [Google Scholar]
  • Sharifi M, Bay C, Skrocki L, et al (2013) Moderate pulmonary embolism treated with thrombolysis (from the “MOPETT” Trial). Am J Cardiol 111:273–277 [CrossRef] [PubMed] [Google Scholar]
  • Marti C, John G, Konstantinides S, et al (2015) Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. Eur Heart J (pii: ehu218. [Epub ahead of print]). [Google Scholar]
  • Kearon C, Akl EA, Comerota AJ, et al (2012) Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141:e419S–e494S [CrossRef] [PubMed] [Google Scholar]
  • Becattini C, Agnelli G, Salvi A, et al (2010) Bolus tenecteplase for right ventricle dysfunction in hemodynamically stable patients with pulmonary embolism. Thromb Res 125:e82–e86. doi:10.1016/j.thromres.2009.09.017. Epub 2009 Oct 14. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.